FAM
IMA

Fred Alger Management’s ImageneBio Inc IMA Stock Holding History

Fred Alger Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,576
Closed -$186K – 473
2023
Q3 		$186K Buy
3,576
+138
+4% +$8.31K ﹤0.01% 406
2023
Q2 		$271K Buy
+3,438
New +$247K ﹤0.01% 421

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fred Alger Management's IMA Position: Q4 2023 in Review

Fred Alger Management sold out of ImageneBio Inc (IMA) in Q4 2023, closing a stake of 3,576 shares — an estimated $186K sold.

Fred Alger Management first reported a position in IMA in Q2 2023 and held it in 2 quarters. The position peaked at $271K in Q2 2023. 54 funds tracked by Wall St. Rank hold IMA as of Q4 2023.

  • Fred Alger Management reported no remaining ImageneBio Inc position as of Q4 2023 after selling out during the quarter.
  • Fred Alger Management sold 3,576 ImageneBio Inc shares in Q4 2023, an estimated $186K.
  • Fred Alger Management first reported a position in ImageneBio Inc in Q2 2023 and held it in 2 quarters.
  • Fred Alger Management's ImageneBio Inc position peaked at $271K in Q2 2023.
  • 54 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2023.

Based on Fred Alger Management's 13F filing for Q4 2023, filed 14 Feb 2024.